| Journal Club 2016-2017 Year to Date Articles |
| June 28, 2016: R. Gill |
| Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A (RG) |
| July 5, 2016: Baby, Kasindi |
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone (JB) |
Combination of Tenofovir Disoproxil Fumarate and Peginterferon a-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B (DK) |
| July 19, 2016: Gannavarapu, Ngo |
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer (BG) |
One-Year Outcomes in Caregivers of Critically Ill Patients (JN) |
| August 2, 2016: Trejo, Ruiz |
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD (ET) |
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MR) |
| August 16, 2016: Gokaraju, Achtman |
Blood Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease (SG) |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs (JA) |
| August 30, 2016: Wunderlich, J. Gill |
Randomized Trial of Thymectomy in Myasthenia Gravis (PW) |
Carbohydrate Antigen 125-Guided Therapy in Acute Heart Failure (JG) |
| September 13, 2016: Khan, Purnell |
| Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma A Randomized Clinical Trial (FK) |
| Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years (CP) |
| September 27, 2016: Gokaraju, Assaf |
| Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (SG) |
| Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery & Supplementary Appendix (AA) |
| October 11, 2016: Hosein, Soleja |
A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes (RH) |
| Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors (DS) |
| October 25, 2016: Yohannan, Reikher |
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (BY) |
| Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime (DR) |
| November 1, 2016: Achtman, Christensen |
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa (JA) |
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older (EC) |
| November 15, 2016: Kingsley, Rajani |
| Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope (JK) |
Romozumab Treatment in Postmenopausal Women With Osteoporosis (AR) |
| November 29, 2016: Yohannan, J. Gill |
| Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma (BY) |
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection (JG) |
| December 13, 2016: Kingsley, Schiano |
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (JK) |
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer (AS) |
| January 3, 2017: Trejo, Ruiz |
Palbociclib and Letrozole in Advanced Breast Cancer (ET) |
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (MR) |
| January 17, 2017: Qureshi, Christensen |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis (SQ) |
Ustekinumab as Induction and Maintenance Therapy for Crohns Disease (EC) |
| January 31, 2017: Reikher, Rajani |
Development of the Canadian Syncope Risk Score to Predict Serious Adverse Events After Emergency Department Assessment of Syncope (DR) |
|
CPAP for prevention of cardiovascular events in Obstructive Sleep Apnea (AR) |
| February 7, 2017: Baby, Purnell |
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease (JB) |
Cardiovascular Event Risk Assessment in Psoriasis Patients Treated with Tumor Necrosis Factor-a Inhibitors Versus Methotrexate (CP) |
| February 21, 2017: Ngo, Stidger |
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 (JN) |
Baricitinib in Patients with Refractory Rheumatoid Arthritis (DS) |
| March 7, 2017: Gannavarapu, Assaf |
| Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection (BG) |
| Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease (AA) |
| March 21, 2017: Mutoro, Qureshi |
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis The HYPRESS Randomized Clinical Trial (NM) |
| Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis (SQ) |
| April 4, 2017: Wunderlich, Schiano |
| Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery (PW) |
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturations (AS) |
| April 18, 2017: Mutoro, Stidger |
Trial of Pregabalin for Acute and Chronic Sciatica (NM) |
| Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study (DS) |
| May 2, 2017: Kasindi, Soleja |
| A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection (DK) |
| Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma (DS) |
| May 16, 2017: Khan, Hosein |
| Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis (FK) |
| Teprotumumuab for Thyroid-Associated Ophthalmopathy (RH) |